Best Pharma Stocks for Long-Term Investors: Growth and Dividends

The size of the pharmaceutical industry in the U.S. in 2023 was estimated to be nearly $575 billion, with an anticipated compound growth rate of about 5.5% through 2030. This key component of the healthcare sector includes both small biotech firms working to develop specialized treatments and much larger, established companies engaging in a wide array of health-related operations.There is a great deal of debate as to whether the smaller or the bigger components of the pharmaceutical industry are better equi ...